This included axonal guidance signaling pathway with 15 novel cilia interactors, Huntington disease signaling with 15 novel interactors, eNOS signaling pathway with 13, Wnt signaling with 6, DARPP32 feedback in cAMP signaling with 8, dopamine receptor signaling with 3, synaptic long-term depression with 7, and synaptic long-term potentiation with 5 novel interactors. This evidence concerns the gene PPP1R1B and Huntington disease.